FDA Inspection 849685 — Merck & Co Inc

Merck & Co Inc — FEI 3002721810

The FDA completed an inspection of Merck & Co Inc on October 8, 2013 in North Wales, PA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 8, 2013
Fiscal Year
2014
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
North Wales, PA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
673021 CFR 314.80(b)Failure to develop written procedures
673221 CFR 314.80(c)(1)(i)Late submission of 15-day report